Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07599215 · ClinicalTrials.gov registry record · NA
A Novel Interruption Management Intervention for New Graduate Nurses During Medication Administration
A NA study, sponsored by Baystate Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 56
- Enrollment target
NCT07599215: Completed NA study, sponsored by Baystate Medical Center.
NCT07599215 is a NA study that has completed, run by Baystate Medical Center. The registered enrollment target is 56 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07599215, a NA study, has completed, sponsored by Baystate Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 56 participants
- Enrollment target
Study Summary
The objective of this study was to evaluate the effect of education in the Stay S.A.F.E. interruption management strategy on nurses' responses to interruptions during simulated medication administration. Primary outcomes included 1) response to the interrupter, including adherence to Stay S.A.F.E. behaviors, and 2) time away from the primary task. Secondary outcomes included 1) medication administration errors and 2) perceived workload as measured by the NASA Task Load Index.
Primary Outcome
The primary outcome is the participant's response to a clinical interruption, assessed using an eye tracking device (ETD). Study personnel recorded interruption management behaviors, Stay S.A.F.E., using a structured data collection tool and whether the participant immediately accepted the interruption ("took report").
Interventions
- OTHER Experimental: Stay S.A.F.E. Interruption Management Education
- OTHER Medication Safety Education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2024-05-13 |
| Est. Completion | 2024-09-25 |
| Phase | NA |
What the finished NCT07599215 record still lists
NCT07599215 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Experimental: Stay S.A.F.E. Interruption Management Education is the first listed.
NCT07599215 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07599215 about?
NCT07599215 is a clinical study titled "A Novel Interruption Management Intervention for New Graduate Nurses During Medication Administration". The objective of this study was to evaluate the effect of education in the Stay S.A.F.E. interruption management strategy on nurses' responses to interruptions during simulated medication administration. Primary outcomes included 1) response to the interrupter, including adherence to Stay S.A.F.E. b...
What is the current status of trial NCT07599215?
This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2024-05-13. Estimated completion is 2024-09-25.
What interventions are being tested in trial NCT07599215?
The interventions under investigation include: Experimental: Stay S.A.F.E. Interruption Management Education (OTHER), Medication Safety Education (OTHER).
Who is sponsoring clinical trial NCT07599215?
This trial is sponsored by Baystate Medical Center, which has 36 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07599215's enrollment target sits among peer trials
56 1262nd of 2000 higher than 737 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI